glp 1 parkinson's disease and neuroprotection Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's Diseases | CNS Drugs GLP-1 and Parkinson's Disease: Research,

Fat Metabolism : GLP-1 has been shown to influence lipid metabolism , improving fat oxidation and supporting fat loss , making it crucial in studies on metabolic health and obesity treatments

This may contribute to its ability to improve tissue healing and recovery from injuries

The pharmacology of CD38/NADase: an emerging target in cancer and diseases of aging

While Tesofensine and 5-Amino-1MQ are currently at the forefront of alternative protocols, several other novel compounds are demonstrating significant clinical potential for metabolic optimization and body recomposition

I would definitely recommend this location